Most Recent
A class action investigation over the data breach that exposed the personal information of almost 10 million Medibank customers is underway, with two law firms teaming up to probe whether the private health insurer is liable for damages.
Medibank will not pay a ransom to a criminal who stole the data of 9.7 million customers, saying it would encourage extortion.
A top orthopaedic surgeon and former NSW Australian of the year has sued Channel Nine and Fairfax for defamation over a recent 60 Minutes episode and articles that appeared in The Age and the Sydney Morning Herald.
A judge has stayed a class action on behalf of 6,000 women allegedly injured by defective pelvic mesh devices after Astora Women's Health filed for bankruptcy in the United States, but questioned how the company had suddenly come to have no assets.
Medibank's woes worsened Wednesday as the insurer revealed data for all 4 million of its current and former customers had been accessed during a cyberattack after initially reporting no customer data had been exposed.
A class action against Bayer over its allegedly defective Essure contraceptive devices has admonished the drug manufacturer’s bid to shield emails considered privileged in similar US litigation, arguing “thoughts and prayers” are needed to sustain the claim.
The fallout from a cyberattack against Medibank continues, with the health insurer revealing sensitive claims data was accessed for customers of its main Medibank branch.
A criminal has accessed sensitive Medibank customer data, including claims information, following a recent cyberattack.
French drug giant Sanofi has appealed a decision giving American biopharmaceutical company Amgen the go-ahead for its patents for a cholesterol-lowering antibody that could be used to treat heart disease, diabetes, stroke and Alzheimer’s.